Intravenous iron treatments for iron deficiency anemia in inflammatory bowel disease: a budget impact analysis of iron isomaltoside 1000 (Monofer) in the UK

• Published in: Expert opinion on drug delivery Vol. 14; no. 12; p. 1439
• Main Authors: Pollock, R F, Muduma, G
• Format: Journal Article
• Language: English
• Published: England 02.12.2017
• Subjects: Anemia, Iron-Deficiency - drug therapy; Anemia, Iron-Deficiency - etiology; Budgets; Disaccharides - administration & dosage; Ferric Compounds - administration & dosage; Glucaric Acid - administration & dosage; Hematinics - administration & dosage; Hematinics - economics; Hematinics - therapeutic use; Humans; Inflammatory Bowel Diseases - complications; Infusions, Intravenous; Iron-Dextran Complex - administration & dosage; Maltose - administration & dosage; Maltose - analogs & derivatives; Retrospective Studies; United Kingdom; iron; Great Britain; intravenous; costs and cost analysis; Iron deficiency anemia; administration

Iron deficiency is the leading cause of anemia in patients with inflammatory bowel disease (IBD). Intravenous iron is the first-line treatment for clinically active IBD or previous oral iron intolerance. The aim of the present study was to develop a comparative model of iron deficiency and delivery...